Immutep IMMP
NASDAQ IMMP
$4.63 -0.03 (-0.54%)
As of: Oct 1, 2026 · 10:25 AM EDT

Immutep (IMMP) EBITDA Margin (2016 - 2017)

Updated

Immutep (IMMP) recorded EBITDA Margin of -528.27% in the year ended Jun 30, 2026, up 43.60 percentage points from -571.87% a year earlier.

Analysis

Immutep (IMMP) EBITDA Margin (2016 - 2017) Analysis & Trends

Starting with the year ended Jun 30, 2010, Immutep's EBITDA Margin history includes 13 years.

  • Annual EBITDA Margin has a four-year change of +18432.47 percentage points (years ended Jun 2022 to Jun 2026).
  • The figure for the year ended Jun 30, 2026 is the highest annual EBITDA Margin since the year ended Jun 30, 2020.
  • Per Business Quant data, IMMP's EBITDA Margin was -571.87% in the year ended Jun 30, 2025 and -18960.74% in the year ended Jun 30, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 35.95%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 49.01%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 6.02%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 33.11%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 46.01%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -124.26%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 39.16%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 39.10%
10 Immutep 33.95 Mn 33.95 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 -811.74%
Mar 31, 2017 -160.92%
Mar 31, 2016 -894.17%
API Access

Immutep EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMMP&period=max&api_key=YOUR_API_KEY